The Impella CP and 5.5 devices are cardiac assist systems used for hemodynamic support in cases of high risk PCI or cardiogenic shock.
They are advanced over a guidewire and placed inside the left ventricle.
One of the reported complications is left ventricular perforation due to catheter manipulation during insertion or repositioning.
In February 2024, The FDA issued a recall regarding Impella left sided blood pumps due to perforation risks.
The company Abiomed, due to reported cases, announced an update to the instructions for use of the Impella CP and Impella 5 point 5 devices to include the possibility of cardiac perforation and the measures to take to prevent it.
Complete and detailed information in the next video:
Fig: Impella CP positioning.
Fig: Impella Tuohy Borst Valve
Fig: Repositioning unit.
Fig: Impella 5.5 position.
Fig: Impella 5.5 repositioning unit.
Tags: impella, iatrogenic, perforation, risk, high risk PCI, HRPCI, shock, cardiogenic shock, complication, FDA, FDA recall, IFU, pacing electrode, pulmonary artery catheter, TAVR, TAVI, ablation catheter, Amplazter closure device, position, Tuohy-Borst valve, sheath, repositioning unit, echocardiogram, impella cp, impella 5.5, fixation, CPR, aneurism.
